Molecular biology is continuing to revolutionize disease diagnosis. Modern molecular tests based on the detection of nucleic acids (ie, DNA and RNA) offer considerable advantages over traditional methods of pathogen detection.
Read More
The new, nearly $1.5 million contract with further the development of a panel of assays designed to provide a fast and accurate way to identify and characterize biomarkers estimated to constitute up to 9% of NSCLC cases.
Read More
The company is working with payors nationwide to make this test available to clinicians and cancer patients.
Read More
Mid America Clinical Laboratories is a joint venture clinical laboratory owned by Quest Diagnostics, Community Health Network, St. Vincent Health, and CoLab.
Read MoreThe meeting will be a forum to learn more about new diagnostic tools and techniques. Hotspot testing will be compared to comprehensive genome profiling, emerging technologies will be explored, including molecular test development.
Read More